Back
X4 Pharmaceuticals Vs. Nukkleus Industry Stock Comparison
Sell
47
XFOR
X4 Pharmaceuticals
Last Price:
$0.60
Seasonality Move:
19.75%
Sell
46
NUKK
Nukkleus
Last Price:
$40.15
Seasonality Move:
-21.57%
Sell
47
X4 Pharmaceuticals (XFOR)
is a Sell
Is X4 Pharmaceuticals a Buy, Sell or Hold?
-
The current X4 Pharmaceuticals [XFOR] share price is $0.61. The Score for XFOR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
XFOR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Nukkleus (NUKK)
is a Sell
Is Nukkleus a Buy, Sell or Hold?
-
NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XFOR Stock Price Chart
What is X4 Pharmaceuticals's stock price today?
-
The X4 Pharmaceuticals share price today is $0.61The current trend is moderately bullish and XFOR is experiencing slight selling pressure.
NUKK Stock Price Chart
XFOR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 55.05 | Buy |
Chaikin Money Flow: | -869878 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.34 - 0.62) | Buy |
Bollinger Bands (100): | (0.46 - 0.7) | Buy |
NUKK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.69 | Buy |
Relative Strength Index (14 RSI): | 77.28 | Buy |
Chaikin Money Flow: | -1366926 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-7.5 - 22.6) | Buy |
Bollinger Bands (100): | (-4.22 - 11.5) | Buy |
XFOR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.66 | Sell |
20-day SMA: | 0.51 | Buy |
50-day SMA: | 0.5 | Buy |
200-day SMA: | 0.8 | Sell |
8-day EMA: | 0.62 | Sell |
20-day EMA: | 0.56 | Buy |
50-day EMA: | 0.54 | Buy |
200-day EMA: | 0.72 | Sell |
NUKK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.07 | Buy |
20-day SMA: | 9 | Buy |
50-day SMA: | 4.99 | Buy |
200-day SMA: | 4.78 | Buy |
8-day EMA: | 26.51 | Buy |
20-day EMA: | 14.21 | Buy |
50-day EMA: | 7.47 | Buy |
200-day EMA: | 11.77 | Buy |
X4 Pharmaceuticals Earnings Growth & XFOR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.44 per share.
Nukkleus Earnings Growth & NUKK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
X4 Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nukkleus Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |